BRCA1 and neoplasm: Interestingly, inhibition of PARP1 was found to be synthetically lethal for cells with defects in homologous recombination HR [129], a DSBs repair mechanism, and was particularly effective in tumor cells that lack functional BRCA1 or BRCA2 [129, 130].